![Kristine Ball](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/09/2026
Dr. Kristine M.
Ball is an Independent Director at Oruka Therapeutics, Inc. She is on the Board of Directors at Enliven Therapeutics, Inc., Oruka Therapeutics, Inc. and National Kidney Foundation of Northern California.
Dr. Ball was previously employed as a President & Chief Executive Officer by Antiva Biosciences, Inc., a Chief Executive Officer & Director by Soteria Biotherapeutics, Inc., an Independent Director by Atreca, Inc., an Independent Director by Forty Seven LLC, a Chief Financial Officer & SVP-Corporate Strategy by Menlo Therapeutics, Inc., a Chief Financial Officer & Senior Vice President by Relypsa, Inc., a CFO, Senior VP-Administration & Finance by KAI Pharmaceuticals, Inc., a Vice President-Finance by Exelixis, Inc., and a Senior Manager by Ernst & Young LLP.
She received her undergraduate degree from Babson College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
-.--% | 02/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| 14/10/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Director/Miembro de la Junta | 14/10/2026 |
National Kidney Foundation of Northern California
 National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ATRECA, INC. | Director/Miembro de la Junta | 01/01/2024 |
Soteria Biotherapeutics, Inc.
 Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Director Ejecutivo | 01/08/2022 |
| FORTY SEVEN, INC. | Director/Miembro de la Junta | 07/04/2020 |
| YARROW BIOSCIENCE, INC. | Director Financiero/CFO | 01/03/2020 |
| RELYPSA INC | Director Financiero/CFO | 01/10/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
National Kidney Foundation of Northern California
National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | |
Soteria Biotherapeutics, Inc.
Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Health Technology |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
